Search for: "STATE OF NEW JERSEY v. S.D." Results 161 - 180 of 198
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Feb 2023, 7:15 am by Evan Schwartz
Chemical Bank, 94 N.Y.2d 418, 422-23, 727 N.E.2d 111, 115, 705 N.Y.S.2d 553, 557 (2000) 7 New Jersey Life Ins. [read post]
29 Mar 2021, 7:10 pm by admin
One New Jersey appellate court upheld the disqualification of an expert witness who had worked for the State of New Jersey on a case that involved confidential disclosures by the State’s lawyers and its agencies, which disclosures were necessarily involved in the expert witness’s subsequent retention by the State’s adversary in a different case.[10] This decision, like most in this area, turned on a close analysis of… [read post]
3 Jun 2022, 10:03 am by Robert B. Milligan
In the case, a pharmaceutical company sued a former product development employee and his new employer in the District of New Jersey for misappropriation of trade secrets in violation of the DTSA. [read post]
28 Jun 2019, 7:36 am by Epstein Becker & Green, P.C.
Numerous other state legislatures, including Missouri’s, New Hampshire’s, and New Jersey’s, recently have considered similar legislation. [read post]
22 Dec 2011, 11:59 am by Bexis
  As step one, Forman held that New Jersey appellate courts didn’t know what they were doing when those courts applied Buckman preemption to the fraud-on-the-FDA exception of New Jersey’s punitive damages statute. [read post]
18 Jan 2007, 7:53 pm
It's about a hot topic - the use and abuse of medical monitoring claims in this type of case.IntroductionOn January 16, 2007, the Appellate Division of the Superior Court of New Jersey handed down a decision in the putative class action case, Sinclair v. [read post]
23 Sep 2009, 10:48 am by Steve
Code §§ 22.1-79, 22.1-125; compare New Jersey v. [read post]
16 Aug 2007, 7:20 am
Hereen, 563 N.W.2d 830, 837 (S.D. 1997) ("waiver of privilege in this case under [statutory physician-patient privilege] is absolute as to an opposing party"); Steinberg v. [read post]
22 Feb 2023, 1:07 pm by Dennis Crouch
As a point of context, it’s worth noting that many states already require disclosure or much more draconian regulation of litigation funders backing state court cases—for instance, some states require funds and funders to register, and some even require funding agreements to be disclosed with the state. [read post]
16 Feb 2011, 12:24 pm by Bexis
§600.2946(4-5) (compliance generally creates rebuttable presumption; FDA approved drugs are not defective unless sold after a recall or plaintiff proves FDA fraud/bribery); New Jersey:  N.J. [read post]
12 Sep 2012, 5:00 am by Steve McConnell
As we said in Monday's post (talking about New Jersey law), we think that sort of thing is preempted by Buckman. [read post]
22 Apr 2021, 5:55 am by Kevin Kaufman
States using a flat-dollar surcharge may levy a one-time surcharge, such as in Massachusetts, or may charge a flat amount per-day, as Hawaii, New Jersey, and West Virginia do. [read post]
28 Apr 2011, 3:18 pm by Bexis
  Each case involves the reweighing of risks and benefits in light of “new information” or a “new . . . safer design. [read post]
23 Mar 2012, 11:13 am by Wahab & Medenica LLC
  And with each day’s headlines new complications and permutations challenge any chance at a one size fits all understanding. [read post]